Navigation Links
Zeus Announces Product Name Changes
Date:2/10/2009

Zeus announces new product names that better reflect the unique properties and industry-leading characteristics of these products.

Orangeburg, SC (PRWEB) February 11, 2009 -- Zeus, Inc. announces new product name changes that signify its commitment to innovation and quality. The selected products are unaltered in composition and processing. They remain the same quality products that Zeus customers have come to expect and trust.

New brand names are as follows:

  • New trademarked product Aeos™, formerly known as ePTFE, is a micro-porous material that is medically implantable and has a low coefficient of friction. The new brand name Aeos was coined after the word "eon" to suggest the material's durability over an extended period of time.

  • New trademarked product Impactiv™, formerly known as Lubricious PEEK™, is a new version of PEEK tubing and can be used anywhere PEEK is used with a need for lower coefficient of friction. The material's new name suggests the product's excellent impact resistance.

  • New trademarked product Absorv™, formerly known as Zeus Biomaterial, receives its new brand name from its distinctive absorptive quality. These absorbable polymers have generated an extreme amount of interest due to their unique ability to perform vital functions in the body and safely absorb after they have carried out their function.

  • New trademarked product DuaTem™, formerly known as Hytem, is a flexible alternative to Ultem and is capable of operating at both high and low service temperatures. The new brand name reflects the dual properties of the product.

About Zeus, Inc.:
Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications; operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit www.zeusinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb1998804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):